Universitätsspital Zürich
Zurich, 8008, Switzerland
NCT Number: NCT04816357
Patients with both, migraine and endometriosis, present the case-group, while women with endometriosis without migraine serve as controls. The primary endpoint is endometriosis stage confirmed by laparascopy compared to the control group. Further points to compare between groups are infertility, dysmenorrhea, dyschezia, dyspareunia, number of operations, family history with first-degree relatives, and age of first symptoms for both conditions and age at first operation.
Secondary endpoints to evaluate in percentages within the migraine group are migraine frequency, migraine aura/non-aura, age at migraine start, hormonal migraine, family history, treatment response, response to prophylactic agents, localization, types of aura and triggers. Other medical conditions and comorbidities like depression will be noted as well as response to Dienogest treatment.
In the questionnaire we will ask 62 Questions overall. The Questions for endometriosis are based on a questionnaire from the world endometriosis research foundation and to evaluate the severity of the migraine we will use the MIDAS (Migraine Disability Assessment) questionnaire (8).
Looking for future studies?
Notify Me18 year–99 year
Female
Observational
Zurich, 8008, Switzerland
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
only questionaire
Time frame: 4 years
endometriosis stage confirmed by laparascopy compared to the control group
Time frame: 4 years
s.o.
Time frame: 4 years
s.o.
Time frame: 4 years
s.o.
Time frame: 4 years
s.o.
Time frame: 4 years
s.o.
Zurich University of Applied Sciences
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06785129
Brain Diseases, Central Nervous System Diseases
St Louis, Missouri, United States
View Trial DetailsNCT07519343
Brain Diseases, Central Nervous System Diseases
Barcelona, Spain
View Trial DetailsNCT03844412
Back Pain, Brain Diseases
Los Angeles, California, United States
View Trial DetailsNCT02214550
Brain Diseases, Central Nervous System Diseases
Evanston, Illinois, United States
View Trial Details